PMDA drug package insert
長城清心丸
PMDA OTC drug · 日邦薬品工業（株） · package insert Mar 11, 2023
Key facts
| Brand names | 長城清心丸 |
|---|---|
| Companies | 製造販売元／アスゲン製薬（株）,販売会社／日邦薬品工業（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | その他 |
| OTC effect category | 生薬主薬製剤 |
| Package insert date | Mar 11, 2023 |
| PMDA document key | 100122_J2101000101 |
| PMDA company code | 100122 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: